✦ LIBER ✦

Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C

✍ Scribed by Luigi Muratori; Marco Lenzi; Michela Cataleta; Fabrizio Giostra; Fabio Cassani; Giorgio Ballardini; Daniela Zauli; Francesco B. Bianchi

Book ID: 118566339
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 598 KB
Volume: 21
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)80395-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steroid and interferon therapy in liver/

Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C

✍ Sandro Vento; Francesco Cainelli; Ercole Concia; Teresa Ferraro 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Low hepatitis C viremia levels in patien

Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis

✍ Fabrizio Giostra; Aldo Manzin; Marco Lenzi; Raffaella Francesconi; Laura Solforo 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 732 KB

Clinical features and effect of antivira

Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C

✍ Silvia Ferri; Luigi Muratori; Chiara Quarneti; Paolo Muratori; Rita Menichella; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Efficacy and safety of interferon alfa t

Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes

✍ Luca Todros; Giorgio Saracco; Marilena Durazzo; Maria Lorena Abate; Giovanni Tou 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Interferon alfa (IFN) therapy is efficacious in chronic viral hepatitides. It may, however, cause adverse immunologic reactions in patients with concomitant autoimmune phenomena. A minority of patients with chronic type C hepatitis have antibodies against liver and kidney microsomes (anti-LKM) in se

Efficacy and safety of interferon alfa t

Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes

✍ Luca Todros; Giorgio Saracco; Marilena Durazzo; Maria Lorena Abate; Giovanni Tou 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Liver kidney microsomal type 1 antibodie

Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection

✍ F. Girardin; Y. Daali; M. Gex-Fabry; M. Rebsamen; P. Roux-Lombard; A. Cerny; F. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB